Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York, founded in 1988 by physician-scientist Leonard S. Schleifer and researcher George D. Yancopoulos. It develops and manufactures medicines derived from its own antibody-discovery technology, including the eye disease treatment Eylea and the immunology drug Dupixent, and grew into one of the leading biotechnology companies in the United States.
Reader Challenges (0 open reader challenges)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
The atlas records no dated fact of its own for this entry, so there is no other year to choose.